Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and ...

In 2023 Dr. Vinay Prasad said that scientists who recognized the limitations of randomized-controlled trials (RCTS) were ...

A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.

FDA Commissioner Marty Makary and CBER Director Vinay Prasad published an article in JAMA on Tuesday outlining the FDA’s ...

The FDA’s accelerated approval pathway plays a vital role, and scrapping it or reversing course on already-approved therapies ...

Public health and infectious disease experts said they were surprised and confused about the move, and questioned why the HHS did not offer any reasoning for its decision.

AI is slowly permeating all corners of the federal government, including the Food and Drug Administration, where, according ...

When two of medicine’s most outspoken reformers publish a roadmap for the FDA, you expect at least coherence. Instead, we get ...

At the CTO West Coast conference, experts discussed the future of oncology clinical trials and key themes surrounding them.

With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...

The new FDA commissioner and Center for Biologics Evaluation and Research (CBER) director laid out their vision for the ...

The Food and Drug Administration has gone all in on AI since Martin Makary, M.D., took over the agency, most recently ...